NO162194C - Radioakt. oestradienderivat, fremgm. ved dets fremst., middel for radioimmunologisk paavisn. og best. in vitro av ikke-radioaktivt 17beta-hydroksy-11beta-(4-dimethylaminofenyl)-17beta-(prop-1-ynyl)-oestra-4,9-dien-3-on og dets metab. - Google Patents

Radioakt. oestradienderivat, fremgm. ved dets fremst., middel for radioimmunologisk paavisn. og best. in vitro av ikke-radioaktivt 17beta-hydroksy-11beta-(4-dimethylaminofenyl)-17beta-(prop-1-ynyl)-oestra-4,9-dien-3-on og dets metab.

Info

Publication number
NO162194C
NO162194C NO841798A NO841798A NO162194C NO 162194 C NO162194 C NO 162194C NO 841798 A NO841798 A NO 841798A NO 841798 A NO841798 A NO 841798A NO 162194 C NO162194 C NO 162194C
Authority
NO
Norway
Prior art keywords
17beta
radioactive
ynyl
dimethylaminophenyl
prop
Prior art date
Application number
NO841798A
Other languages
English (en)
Norwegian (no)
Other versions
NO841798L (no
NO162194B (no
Inventor
Alain Jouquey
Jean-Noel Veltz
Jean Salmon
Michel Mouren
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NO841798L publication Critical patent/NO841798L/no
Publication of NO162194B publication Critical patent/NO162194B/no
Publication of NO162194C publication Critical patent/NO162194C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO841798A 1983-06-14 1984-05-04 Radioakt. oestradienderivat, fremgm. ved dets fremst., middel for radioimmunologisk paavisn. og best. in vitro av ikke-radioaktivt 17beta-hydroksy-11beta-(4-dimethylaminofenyl)-17beta-(prop-1-ynyl)-oestra-4,9-dien-3-on og dets metab. NO162194C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8309812A FR2549067B1 (fr) 1983-06-14 1983-06-14 Derives estradieniques radioactifs marques au tritium, leur procede de preparation et leur application pour l'etude et le dosage radio-immunologique de steroides dans les fluides biologiques

Publications (3)

Publication Number Publication Date
NO841798L NO841798L (no) 1984-12-17
NO162194B NO162194B (no) 1989-08-14
NO162194C true NO162194C (no) 1989-11-22

Family

ID=9289759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841798A NO162194C (no) 1983-06-14 1984-05-04 Radioakt. oestradienderivat, fremgm. ved dets fremst., middel for radioimmunologisk paavisn. og best. in vitro av ikke-radioaktivt 17beta-hydroksy-11beta-(4-dimethylaminofenyl)-17beta-(prop-1-ynyl)-oestra-4,9-dien-3-on og dets metab.

Country Status (9)

Country Link
US (1) US4661295A (de)
EP (1) EP0135400B1 (de)
JP (2) JPS6011499A (de)
AT (1) ATE34752T1 (de)
CA (2) CA1222744A (de)
DE (1) DE3471660D1 (de)
FI (1) FI83785C (de)
FR (1) FR2549067B1 (de)
NO (1) NO162194C (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2785023B2 (ja) * 1987-12-30 1998-08-13 ルセル―ユクラフ 17α位置を置換された17β―OH―19―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
DE59010853D1 (de) * 1989-08-04 1998-12-03 Schering Ag 11 Beta-Aryl-gona-4,9-dien-3-one
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ATE156836T1 (de) * 1994-05-19 1997-08-15 Akzo Nobel Nv 11,21-bisphenyl-19-nor-pregnan derivate
AU2019351004B2 (en) * 2018-09-28 2023-09-14 The Regents Of The University Of Michigan Halogenated cholesterol analogues and methods of making and using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2414515A1 (fr) * 1978-01-11 1979-08-10 Roussel Uclaf Steroides marques au tritium, leur procede de preparation et leur application dans la synthese de derives de l'estrane marques au tritium
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained

Also Published As

Publication number Publication date
FR2549067A1 (fr) 1985-01-18
EP0135400A2 (de) 1985-03-27
FI842398L (fi) 1984-12-15
JPS6034989A (ja) 1985-02-22
JPS6011499A (ja) 1985-01-21
US4661295A (en) 1987-04-28
EP0135400A3 (en) 1985-08-14
ATE34752T1 (de) 1988-06-15
EP0135400B1 (de) 1988-06-01
FI83785C (fi) 1991-08-26
NO841798L (no) 1984-12-17
DE3471660D1 (en) 1988-07-07
FR2549067B1 (fr) 1985-12-27
FI842398A0 (fi) 1984-06-13
FI83785B (fi) 1991-05-15
NO162194B (no) 1989-08-14
CA1222744A (fr) 1987-06-09
CA1242695A (fr) 1988-10-04

Similar Documents

Publication Publication Date Title
ATE29265T1 (de) Neue redox-indikatoren.
ES512381A0 (es) "procedimiento de preparacion de disacaridos".
DK374083A (da) Cyclovitamin-d forbindelser
ES504702A0 (es) Procedimiento de fabricacion y de aplicacion de derivados iridoides reactivos
DE3471660D1 (en) Estradiene derivatives labelled with tritium, their preparation and intermediates for their preparation, and their utilization in the study and in the determination of steroids in biological fluids
DE3262905D1 (en) Chlorinated beta-ketoesters, their preparation and their use
FI842397A0 (fi) Foerfarande foer framstaellning av radioaktiva steroider och deras mellanprodukter, deras laemplighet foer paovisande av glukokortikoidreceptorer och bestaemmande av antalet bindningstaellen.
NO154880C (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser.
NO824253L (no) 2-amino-1-(1,3-dioxolan-4-yl)-ethanolforbindelser, fremstilling av disse og anvendelse av disse som utgangsmaterialer
RO83669A (ro) Procedeu de preparare a unor derivati ai 6-alfa-metilhidrocortizonului
IE791781L (en) 4, 5-methano-bufadienolide rhamnosides
PT74343B (fr) Nouveau procede de preparation de 17 alpha-hydroxy 17 beta- -hydroxyacetyl steroides
GB1538037A (en) Process for the preparation of prostaglandins
ES478210A1 (es) Un procedimiento de preparacion de derivados de la xantona.
JPS5699500A (en) Novel corticoidd177thioacetal* its manufacture and antiinflammatory medicine containing it
KR830005179A (ko) 아세트 아닐리드의 제조방법
KR870000303A (ko) 신규 피라졸린 화합물의 제조방법
ES480141A1 (es) Procedimiento para la preparacion de derivados 6-oxigenados-3, 20-dioxo-pregnano.